Personal responses to danger in Greek graffiti: inscriptional formulae and self-expression at three late antique and Byzantine sites
Byzantine and Modern Greek Studies · 2025-10 · 49 (2) · 165-186
DOI: 10.1017/byz.2024.14 ↗Kurz gefasst
Fachartikel in der Zeitschrift Byzantine and Modern Greek Studies, online erschienen am 14.11.2024. Verfasst von Rachael Helen Banes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Austrian Science Fund.
Abstract (Originalsprache)
Graffiti are often seen as providing a window into the emotions of ancient peoples. However, Byzantine graffiti has been viewed as an exception, with the formulaic Greek texts written between 300 and 1500 taken as evidence of communal identity, rather than individual expressiveness. However, variations in these texts can reveal much about an individual author and their personal experiences. In particular, certain formula suggest the dangerous situation an author survived, including incarceration and sea travel. This paper focuses on Corinth, Syros, and Tinos where individuals experienced danger, and how their fears and needs were manifested in the graffiti they left behind.
Förderung
- Austrian Science Fund
Zitieren
APA
Banes, R. H. (2025). Personal responses to danger in Greek graffiti: inscriptional formulae and self-expression at three late antique and Byzantine sites. Byzantine and Modern Greek Studies, 49(2), 165-186. https://doi.org/10.1017/byz.2024.14
Vancouver
Banes RH. Personal responses to danger in Greek graffiti: inscriptional formulae and self-expression at three late antique and Byzantine sites. Byzantine and Modern Greek Studies. 2025;49(2):165-186. doi:10.1017/byz.2024.14
BibTeX
@article{Banes2025,
author = {Banes, Rachael Helen},
title = {Personal responses to danger in Greek graffiti: inscriptional formulae and self-expression at three late antique and Byzantine sites},
journal = {Byzantine and Modern Greek Studies},
year = {2025},
volume = {49},
number = {2},
pages = {165--186},
doi = {10.1017/byz.2024.14}
}
EUVIMED